Ledipasvir and Sofosbuvir Tablets and Omeprazole Delayed-Release Capsules
Determining the interaction of Ledipasvir and Sofosbuvir Tablets and Omeprazole Delayed-Release Capsules and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Depending on the dose, omeprazole may interfere with the absorption of ledipasvir and reduce its effectiveness. Talk to your doctor or pharmacist if you have any questions or concerns. You may need a dose adjustment of omeprazole to safely use both medications. You should take omeprazole simultaneously with the dose of ledipasvir on an empty stomach. Contact your doctor if your symptoms worsen or your condition changes. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:ADJUST DOSE: Coadministration of ledipasvir with proton pump inhibitors may reduce its gastrointestinal absorption. Ledipasvir exhibits pH-dependent solubility, with increased solubility at lower pH. In 17 healthy volunteers, mean ledipasvir peak plasma concentration (Cmax) and systemic exposure (AUC) decreased by 48% and 42%, respectively, when a single 30 mg dose of ledipasvir was administered 2 hours after omeprazole given at a dosage of 20 mg once daily. When a single 90 mg-400 mg dose of ledipasvir-sofosbuvir was administered simultaneously with omeprazole 20 mg once daily, mean ledipasvir Cmax decreased by 11% and AUC decreased by just 4%.
MANAGEMENT: Proton-pump inhibitors at doses comparable to omeprazole 20 mg or lower should only be administered either simultaneously with or up to 2 hours after ledipasvir-sofosbuvir under fasted conditions. Some authorities advise against administering proton pump inhibitors before ledipasvir-containing products; however, a timeframe of dosage separation has not been specified.
- "Product Information. Harvoni (ledipasvir-sofosbuvir)." Gilead Sciences, Foster City, CA.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
Generic Name: ledipasvir / sofosbuvir
Brand name: Harvoni
Synonyms: Ledipasvir and sofosbuvir, Ledipasvir and Sofosbuvir
Generic Name: omeprazole
Brand name: FIRST Omeprazole, Omeprazole + SyrSpend SF Alka, Prilosec, Prilosec OTC, Zegerid>, Prilosec, Prilosec OTC
Synonyms: Omeprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ledipasvir and Sofosbuvir Tablets-Omeprazole Delayed-Release Capsules and Tablets (OTC)
- Ledipasvir and Sofosbuvir Tablets-Omeprazole Orally-Disintegrating Tablets
- Ledipasvir and Sofosbuvir Tablets-Omeprazole Powder for Oral Suspension
- Ledipasvir and Sofosbuvir Tablets-Omeprazole Tablets
- Ledipasvir and Sofosbuvir Tablets-Omeprazole, Clarithromycin, and Amoxicillin
- Ledipasvir and Sofosbuvir Tablets-Omidria
- Omeprazole Delayed-Release Capsules-Leena
- Omeprazole Delayed-Release Capsules-Lefamulin
- Omeprazole Delayed-Release Capsules-Lefamulin Acetate
- Omeprazole Delayed-Release Capsules-Lefamulin Injection
- Omeprazole Delayed-Release Capsules-Lefamulin Tablets
- Omeprazole Delayed-Release Capsules-Leflunomide